HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"L 262/16
EN
Official Journal of the European Union
6.10.2011
DECISION OF THE EEA JOINT COMMITTEE
No 63/2011
of 1 July 2011
amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement
THE EEA JOINT COMMITTEE,
(2) the following points shall be inserted after point 94
(Commission Decision 2010/221/EU) in Part 4.2:
Having regard to the Agreement on the European Economic
Area, as amended by the Protocol adjusting the Agreement
‘95. 32010 D 0591: Commission Decision 2010/591/EU
on the European Economic Area, hereinafter referred to as
of 1 October 2010 authorising a laboratory in Russia
‘the Agreement’, and in particular Article 98 thereof,
to carry out serological tests to monitor the
effectiveness of rabies vaccines (OJ L 260, 2.10.2010,
Whereas:
p. 21).
(1) Annex
I
to
the
Agreement
was
amended
by
Decision
of
This act shall not apply to Iceland.
the EEA Joint Committee No 115/2010 of 10 November
2010 ( 1 ).
96. 32011 D 0091: Commission Decision 2011/91/EU of
(2) Commission
Regulation
(EU)
No
1142/2010
of
10 February 2011 authorising a laboratory in the
7 December 2010 amending Regulation (EC) No
Republic of Korea to carry out serological tests to
1266/2007 as regards the period of application of the
monitor the effectiveness of rabies vaccines (OJ L 37,
transitional measures concerning the conditions for
11.2.2011, p. 18).
exempting certain animals from the exit ban provided
for in Council Directive 2000/75/EC ( 2 ) is to be incor
This act shall not apply to Iceland.’.
porated into the Agreement.
Article 2
(3) Commission
Decision
2010/591/EU
of
1
October
2010
authorising a laboratory in Russia to carry out serological
The texts of Regulation (EU) No 1142/2010 and Decisions
tests to monitor the effectiveness of rabies vaccines ( 3 ) is
2010/591/EU and 2011/91/EU in the Norwegian language, to
to be incorporated into the Agreement.
be published in the EEA Supplement to the Official Journal of the
European Union, shall be authentic.
(4) Commission
Decision
2011/91/EU
of
10
February
2011
authorising a laboratory in the Republic of Korea to carry
Article 3
out serological tests to monitor the effectiveness of rabies
vaccines ( 4 ) is to be incorporated into the Agreement.
This Decision shall enter into force on 2 July 2011, provided
that all the notifications pursuant to Article 103(1) of the
(5) This Decision is not to apply to Iceland and
Agreement have been made to the EEA Joint Committee (*).
Liechtenstein,
Article 4
HAS ADOPTED THIS DECISION:
This Decision shall be published in the EEA Section of, and in
Article 1
the EEA Supplement to, the Official Journal of the European
Union.
Chapter I of Annex I to the Agreement shall be amended as
follows:
(1) the following indent shall be added in point 40
Done at Brussels, 1 July 2011.
(Commission Regulation (EC) No 1266/2007) in Part 3.2:
For the EEA Joint Committee
‘— 32010 R 1142: Commission Regulation (EU) No
1142/2010 of 7 December 2010 (OJ L 322,
The President
8.12.2010, p. 20).’;
Kurt JGER
( 1 ) OJ L 58, 3.3.2011, p. 69.
( 2 ) OJ L 322, 8.12.2010, p. 20.
( 3 ) OJ L 260, 2.10.2010, p. 21.
( 4 ) OJ L 37, 11.2.2011, p. 18. (*)
No
constitutional
requirements
indicated.

---